# Perspectum, Ltd.

- Location (FDA's records): Oxford, GB
- FDA decisions: 8 (2020–2026): 8 510(k) clearances
- Names in FDA's records: Perspectum, Ltd. (5); Perspectum (3)
- Product codes: LNH (5), LLZ (3)
- 510(k) review time since 2016: median 92 days, against 124 for FDA's reviews in the same codes and years (5 of 8 faster)
- Predicates its devices cite: 12 (4 its own); citations of its devices by later devices: 4 (4 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Perspectum Diagnostics, Ltd.: 3 (https://510kreport.com/company/perspectum-diagnostics)
- Olea Medical: 1 (https://510kreport.com/company/olea-medical)
- Circle Cardiovascular Imaging, Inc.: 1 (https://510kreport.com/company/circle-cardiovascular-imaging)
- Pixmeo Sarl: 1 (https://510kreport.com/company/pixmeo)
- Amra Medical AB: 1 (https://510kreport.com/company/amra-medical)
- Inner Vision Biometrics Pty, Ltd.: 1 (https://510kreport.com/company/inner-vision-biometrics)

## Its most-cited devices
- K202170: LiverMultiScan (2020), cited by 2
- K212565: CoverScan v1 (2022), cited by 1
- K213960: LiverMultiScan v5 (LMSv5) (2022), cited by 1

## Recent decisions
- K253413: LiverMultiScan (v6.0) (Mar 9, 2026)
- K241925: VitruvianScan (v1.0) (Oct 2, 2024)
- K233930: MRCP+ version 2 (MRCP+ v2) (Mar 13, 2024)
- K230294: CoverScan (CoverScan v1.1) (Mar 3, 2023)
- K213960: LiverMultiScan v5 (LMSv5) (Sep 6, 2022)
- K212565: CoverScan v1 (May 19, 2022)
- K203280: Hepatica v1 (Hepatica v1.0.0) (Jan 12, 2021)
- K202170: LiverMultiScan (Oct 2, 2020)

Source page: https://510kreport.com/company/perspectum